|
Educational Course
Lung Imaging |
|
Lung Imaging
Weekday Course
ORGANIZERS: Kathryn Fowler, Catherine Hines, Kartik Jhaveri, Lorenzo Mannelli, Valeria Panebianco, Scott Reeder, Reiko Woodhams
Thursday, 21 June 2018
| S01 |
13:15 - 15:15 |
Moderators: James Quirk |
Skill Level: Intermediate to Advanced
Session Number: Th-04
Overview
This two-hour session will address clinical challenges associated with imaging lung disease and highlight cutting-edge techniques to address these challenges.
Target Audience
This course is aimed at radiologists, imaging scientists, and MR technologists who wish to review the state-of-art MRI protocols and indications for assessment of lung diseases.
Educational Objectives
As a result of attending this course, participants should be able to:
-Describe the potential clinical use of hyperpolarized gas in the lung;
-Discuss MRI techniques for evaluating pulmonary vascular disease; and
-Review MRI techniques for structural and functional imaging of the lung.
13:15
|
|
 Hyperpolarized Gas: Clinical Applications or No?
Edwin van Beek
Hyperpolarized gas MR imaging has shown promising results since its first evaluations began in the mid 1990s. However, after implementation of hyperpolarized 3-He MRI was showing of interest, conflicts with other fields requiring this gas made long-term application and translation impossible. This has driven developments of 129-Xe MRI as an alternative, and following hardware, polarization and sequence changes, this method is now surging in applications and is being used for a variety of pathophysiological processes (that even go beyond the lung).
This presentation will highlight some of the latest developments and will offer a glimpse at the future of hyperpolarized 129-Xe MRI.
|
13:45
|
 |
MRI for Stratifying Pulmonary Vascular Disease
Christopher François
This presentation will review the role of pulmonary MRA and cardiac MRI in the diagnosis and management of patients with pulmonary vascular disease. The primary focus will be on the identification of the signs of pulmonary hypertension on MRA and the findings of right ventricle dysfunction in patients with pulmonary vascular disease.
|
14:15
|
|
MRI for Pulmonary Parenchymal Disease (COPD, IPF)
Jens Vogel-Claussen
Chronic obstructive pulmonary disease (COPD) and interstitial pulmonary fibrosis (IPF) are heterogeneous diseases with different features and phenotypes. Accordingly, one goal is the development of ways to identify regional lung structure and function in these patients to improve patient care and outcomes. Although forced vital capacity is validated for the assessment of COPD and IPF progression and prediction of mortality, the need for tests that are more sensitive to pathophysiological change in the lungs is well recognized for earlier diagnosis, longitudinal assessment and for better markers of therapy and prognosis.
|
14:45
|
|
Oxygen-Enhanced MRI: Ready for Clinical Use?
Yoshiharu Ohno
In this lecture, I present 1) theory of oxygen-enhancement; 2) clinical study results; and 3) future direction and new technique for oxygen-enhanced MR imaging.
|
15:15
|
|
Adjournment & Meet the Teachers |
|
| Back |
| The International Society for Magnetic Resonance in Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. |
